Nexstim Oyj (NXTMH) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Nexstim Oyj (NXTMH) has a cash flow conversion efficiency ratio of 0.099x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€314.60K ≈ $367.80K USD) by net assets (€3.18 Million ≈ $3.72 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Nexstim Oyj - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how Nexstim Oyj's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Nexstim Oyj balance sheet liabilities for a breakdown of total debt and financial obligations.
Nexstim Oyj Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nexstim Oyj ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Man Zai Industrial Co Ltd
TWO:4543
|
0.047x |
|
Dominari Holdings Inc.
NASDAQ:DOMH
|
0.386x |
|
Sab Zenzele Kabili Holdings
JSE:SZK
|
0.020x |
|
Eyenovia Inc
NASDAQ:EYEN
|
0.457x |
|
Making Science Group S.A.
MC:MAKS
|
0.767x |
|
BARK, Inc.
NYSE:BARK
|
0.021x |
|
XXL ASA
OL:XXL
|
-0.085x |
|
Argosy Minerals Ltd
AU:AGY
|
-0.008x |
Annual Cash Flow Conversion Efficiency for Nexstim Oyj (2012–2024)
The table below shows the annual cash flow conversion efficiency of Nexstim Oyj from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see NXTMH stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €3.70 Million ≈ $4.33 Million |
€1.88 Million ≈ $2.20 Million |
0.508x | +163.55% |
| 2023-12-31 | €2.84 Million ≈ $3.32 Million |
€-2.27 Million ≈ $-2.65 Million |
-0.800x | -424.79% |
| 2022-12-31 | €4.07 Million ≈ $4.76 Million |
€1.00 Million ≈ $1.17 Million |
0.246x | +130.21% |
| 2021-12-31 | €3.20 Million ≈ $3.74 Million |
€-2.61 Million ≈ $-3.05 Million |
-0.815x | -143.95% |
| 2020-12-31 | €-1.47 Million ≈ $-1.72 Million |
€-2.72 Million ≈ $-3.19 Million |
1.855x | -79.46% |
| 2019-12-31 | €-740.06K ≈ $-865.21K |
€-6.68 Million ≈ $-7.81 Million |
9.028x | -57.10% |
| 2018-12-31 | €-294.27K ≈ $-344.04K |
€-6.19 Million ≈ $-7.24 Million |
21.043x | +2250.25% |
| 2017-12-31 | €5.52 Million ≈ $6.45 Million |
€-5.40 Million ≈ $-6.32 Million |
-0.979x | +39.34% |
| 2016-12-31 | €4.48 Million ≈ $5.24 Million |
€-7.23 Million ≈ $-8.45 Million |
-1.613x | +40.48% |
| 2015-12-31 | €3.55 Million ≈ $4.14 Million |
€-9.61 Million ≈ $-11.23 Million |
-2.710x | -199.06% |
| 2014-12-31 | €8.59 Million ≈ $10.04 Million |
€-7.79 Million ≈ $-9.10 Million |
-0.906x | -154.19% |
| 2013-12-31 | €-2.38 Million ≈ $-2.78 Million |
€-3.98 Million ≈ $-4.66 Million |
1.672x | +116.57% |
| 2012-12-31 | €304.81K ≈ $356.35K |
€-3.08 Million ≈ $-3.60 Million |
-10.090x | -- |
About Nexstim Oyj
Nexstim Plc, a medical technology company, engages in the development of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally. The company's transcranial magnetic stimulation (TMS) is a non-invasive neuromodulation technique whereby pulses of electromagnetic fields target and interact with specific brain regions from outside the head. It provi… Read more